Physician profile
Scott Strum
NPI 1023039609
$7,244.29
in general payments reported to CMS, 2019-2025
10 companies · $305 in 2025
The $305 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $531 · 2020: $68.82 · 2021: $5,299 · 2022: $367 · 2023: $553 · 2024: $121 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $979.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $979.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $5,658.53 | 2019-2024 | Senza |
| Saluda Medical Americas, INC. | $400.28 | 2023-2025 | Evoke Scs, Evoke |
| Abbott Laboratories | $352.73 | 2019-2025 | Proclaim |
| Boston Scientific Corporation | $272.97 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Painteq LLC | $164.52 | 2022 | |
| Medtronic, INC. | $96.61 | 2023 | Intellis Adaptivestim |
| Biotronik Nro, INC. | $84.40 | 2025 | Prospera |
| Spr Therapeutics, INC | $75.00 | 2023 | Sprint Pns System |
| Globus Medical, INC. | $71.90 | 2025 | Senza |
| Tonix Medicines, INC. | $67.35 | 2025 | Tonmya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Strum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.